Suppr超能文献

用于研究G蛋白偶联受体结构与功能的纳米抗体

Nanobodies to Study G Protein-Coupled Receptor Structure and Function.

作者信息

Manglik Aashish, Kobilka Brian K, Steyaert Jan

机构信息

Department of Molecular and Cellular Physiology, Stanford University, Stanford, California 94305; email:

Structural Biology Brussels, Vrije Universiteit Brussel, 1050 Brussels, Belgium; email:

出版信息

Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:19-37. doi: 10.1146/annurev-pharmtox-010716-104710. Epub 2016 Dec 7.

Abstract

Ligand-induced activation of G protein-coupled receptors (GPCRs) is a key mechanism permitting communication between cells and organs. Enormous progress has recently elucidated the structural and dynamic features of GPCR transmembrane signaling. Nanobodies, the recombinant antigen-binding fragments of camelid heavy-chain-only antibodies, have emerged as important research tools to lock GPCRs in particular conformational states. Active-state stabilizing nanobodies have elucidated several agonist-bound structures of hormone-activated GPCRs and have provided insight into the dynamic character of receptors. Nanobodies have also been used to stabilize transient GPCR transmembrane signaling complexes, yielding the first structural insights into GPCR signal transduction across the cellular membrane. Beyond their in vitro uses, nanobodies have served as conformational biosensors in living systems and have provided novel ways to modulate GPCR function. Here, we highlight several examples of how nanobodies have enabled the study of GPCR function and give insights into potential future uses of these important tools.

摘要

配体诱导的G蛋白偶联受体(GPCRs)激活是细胞与器官之间进行通讯的关键机制。最近取得的巨大进展阐明了GPCR跨膜信号传导的结构和动态特征。纳米抗体是骆驼科仅重链抗体的重组抗原结合片段,已成为将GPCR锁定在特定构象状态的重要研究工具。活性状态稳定纳米抗体阐明了激素激活的GPCRs的几种激动剂结合结构,并提供了对受体动态特征的深入了解。纳米抗体还被用于稳定瞬时GPCR跨膜信号复合物,首次对GPCR跨细胞膜的信号转导提供了结构上的见解。除了在体外的应用,纳米抗体还作为活系统中的构象生物传感器,并提供了调节GPCR功能的新方法。在这里,我们重点介绍几个纳米抗体如何促进GPCR功能研究的例子,并深入探讨这些重要工具未来可能的用途。

相似文献

1
Nanobodies to Study G Protein-Coupled Receptor Structure and Function.用于研究G蛋白偶联受体结构与功能的纳米抗体
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:19-37. doi: 10.1146/annurev-pharmtox-010716-104710. Epub 2016 Dec 7.
4
Nanobodies as sensors of GPCR activation and signaling.纳米抗体作为 G 蛋白偶联受体激活和信号转导的传感器。
Methods Cell Biol. 2021;166:161-177. doi: 10.1016/bs.mcb.2021.06.008. Epub 2021 Jul 30.
9
Nanobody stabilization of G protein-coupled receptor conformational states.纳米抗体稳定 G 蛋白偶联受体构象状态。
Curr Opin Struct Biol. 2011 Aug;21(4):567-72. doi: 10.1016/j.sbi.2011.06.011. Epub 2011 Jul 21.

引用本文的文献

4
Nanobodies: From Discovery to AI-Driven Design.纳米抗体:从发现到人工智能驱动的设计
Biology (Basel). 2025 May 14;14(5):547. doi: 10.3390/biology14050547.
7
Epitope-directed selection of GPCR nanobody ligands with evolvable function.具有可进化功能的GPCR纳米抗体配体的表位导向选择。
Proc Natl Acad Sci U S A. 2025 Mar 18;122(11):e2423931122. doi: 10.1073/pnas.2423931122. Epub 2025 Mar 11.
9
Trends in nanobody radiotheranostics.纳米抗体放射诊疗学的发展趋势。
Eur J Nucl Med Mol Imaging. 2025 May;52(6):2225-2238. doi: 10.1007/s00259-025-07077-6. Epub 2025 Jan 13.

本文引用的文献

3
GPCRdb: an information system for G protein-coupled receptors.GPCRdb:G蛋白偶联受体信息系统。
Nucleic Acids Res. 2016 Jan 4;44(D1):D356-64. doi: 10.1093/nar/gkv1178. Epub 2015 Nov 17.
6
How Can Mutations Thermostabilize G-Protein-Coupled Receptors?突变如何使G蛋白偶联受体具有热稳定性?
Trends Pharmacol Sci. 2016 Jan;37(1):37-46. doi: 10.1016/j.tips.2015.09.005. Epub 2015 Nov 5.
7
Transient conformers of LacY are trapped by nanobodies.乳糖转运蛋白(LacY)的瞬时构象被纳米抗体捕获。
Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13839-44. doi: 10.1073/pnas.1519485112. Epub 2015 Oct 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验